Icon

VIOXX (nda021042)- (12.5MG,25MG,50MG)

ROFECOXIB MERCK
12.5MG,25MG,50MG
No No
2017-Nov-25 Expired
None None
None No
VIOXX is indicated:  For relief of the signs and symptoms of osteoarthritis.  For relief of the signs and symptoms of rheumatoid arthritis in adults.  For relief of the signs and symptoms of pauciarticular or polyarticular course Juvenile Rheumatoid Arthritis (JRA) in patients 2 years and older and who weigh 10 kg (22 lbs) or more.  For the management of acute pain in adults.  For the treatment of primary dysmenorrhea.  For the acute treatment of migraine attacks with or without aura in adults.
0 0 0
Total Other Developers None
Drugs with Suitability No
12.5MG ** ** - - -
25MG ** ** - - -
50MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.